NCT04618341 is a clinical trial in Anxiety, sponsored by Revival Active.

Who is sponsoring NCT04618341?

NCT04618341 is sponsored by Revival Active.

What condition does NCT04618341 study?

NCT04618341 studies Anxiety, Depression.

Is NCT04618341 still recruiting?

NCT04618341 is currently completed. Last updated 5 November 2020.

Last reviewed 2020-11-05 · How we verify

NCT04618341

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Study of Online Active Play Program With Adolescents

Completed Last updated 5 November 2020

What this trial tests

trial in Anxiety in 32 participants. Completed in 28 July 2020.

Timeline

30 March 2020

Primary endpoint
30 June 2020

28 July 2020

Quick facts

Lead sponsor	Revival Active
Status	Completed
Study type	OBSERVATIONAL
Enrollment	32
Start date	30 March 2020
Primary completion	30 June 2020
Estimated completion	28 July 2020
Sites	1 location across United Kingdom

Conditions studied

Anxiety — all drugs for Anxiety →
Depression — all drugs for Depression →

Sponsor

Revival Active

Who can join

Adults 11 to 17, any sex, with Anxiety or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the efficacy of an online, active play program (Revival Active Program) in reducing the symptoms of anxiety and depression in community-based adolescents,, a retrospective community based participatory research was conducted with 32 adolescents aged between 11-17 years old. Program was conducted during Covid-19 lockdown from March 2020 to June 2020 to support children and families in isolation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting

Other Revival Active trials

Trials by the same sponsor.

NCT04618562 — Revival Active Program for Adolescents With Depression · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04618341 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Revival Active
Last refreshed: 5 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04618341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing